Common Protein Biomarkers Assessed by Reverse Phase Protein Arrays Show Considerable Intratumoral Heterogeneity in Breast Cancer Tissues-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Common Protein Biomarkers Assessed by Reverse Phase Protein Arrays Show Considerable Intratumoral Heterogeneity in Breast Cancer Tissues

Published:2012-07-05 Issue:7 Volume:7 Page:e40285
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Malinowsky Katharina,Raychaudhuri Mithu,Buchner Theresa,Thulke Sabrina,Wolff Claudia,Höfler Heinz,Becker Karl-Friedrich,Avril Stefanie

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference28 articles.

1. Prognostic molecular markers in early breast cancer.;FJ Esteva;Breast Cancer Res,2004

2. HER2 breast cancer therapies: a review.;CG Murphy;Biologics,2009

3. The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression.;G Berx;Breast Cancer Res,2001

4. Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients.;MP Look;J Natl Cancer Inst,2002

5. Assessment of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in Breast Cancer Tissue: Historical Aspects and Future Prospects.;M Schmitt;Breast Care (Basel),2008

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pan-HER, an antibody mixture, simultaneously targeting EGFR, HER2, and HER3 effectively overcomes resistance to anti-EGFR antibodies;Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies;2023

2. A reverse phase protein array based phospho-antibody characterization approach and its applicability for clinical derived tissue specimens;Scientific Reports;2022-12-26

3. Spatial protein heterogeneity analysis in frozen tissues to evaluate tumor heterogeneity;PLOS ONE;2021-11-19

4. Liquid-phase electron microscopy of molecular drug response in breast cancer cells reveals irresponsive cell subpopulations related to lack of HER2 homodimers;Molecular Biology of the Cell;2017-11-07

5. Histopathological markers of treatment response and recurrence risk in ovarian cancers and borderline tumors;Der Pathologe;2017-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3